fbpx

Current Trials in Pflugerville, TX

1601 E. Pflugerville Pkwy, Ste 1101
Pflugerville, TX 78660

(512) 279-2545

Enrolling Clinical Research Studies


Dermatology

Urticaria (Chronic Spontaneous)

  • Ages 18 yrs and Older
  • Diagnosis of CSU of at least 6 months
  • Injectable Medication
  • 72 Week Study Duration; 18 Office Visits
  • May be Compensated for Time and Travel up to $1,600.00

(Upcoming) Plaque Psoriasis and Obesity

  • Ages 18 or older
  • Subjects with a BMI > 27 and have initiated treatment with Taltz in the last 2-4 months
  • Subcutaneous Injectable Medication
  • 12 Month Study Duration; 4 Visits
  • May Be Compensated Up To $360 and receive a GLP-1 medication for a year

Hidradenitis Suppurativa

  • Ages 18 yrs and Older
  • Moderate to severe HS
  • Pill taken twice daily
  • 16 visits over the course of 68 weeks
  • May be Compensated for Time and Travel Up To $1,768

(Upcoming) Alopecia Areata, Pediatric

  • Ages 6-12 
  • Severe Alopecia Areata 
  • Oral Medication
  • Placebo controlled, 24 Week Study; 9 Office Visits
  • Option to enroll in a long term extension study
  • May Be Compensated for Time and Travel Up To $600

Lichen Simplex Chronicus (Mod-Sev)

  • Ages 18 yrs and Older
  • Diagnosis of Moderate to Severe LSC for at least 6 months
  • Injectable Medication, Placebo Controlled
  • 36 Week Study Duration; 6 Office Visits
  • May be Compensated for Time and Travel up to $450.00

Cutaneous T-Cell Lymphoma (CTCL)

  • Ages 18 yrs or Older
  • 2 visits per week during Treatment Phase
  • Topical Medication with UV Light Therapy
  • 30 Week Study Duration
  • May be Compensated for Time and Travel up to $3,200

Genital Psoriasis

  • Ages 18 and Older
  • Moderate to Severe Genital Psoriasis
  • Subcutaneos Injection
  • Placebo Controlled
  • 72 Week Study Duration; 16 Visits
  • May Be Compensated Up to $1,200

Future Studies

Upcoming Studies

Click to add your name to the waiting list for upcoming studies. We will alert you when we begin a new study. Please provide your email address if possible.